What is Palbociclib?
Palbociclib is a CDK4/6 inhibitor used in combination with hormone therapy (like Letrozole or Fulvestrant) to treat hormone receptor-positive (HR+), HER2-negative advanced or metastatic breast cancer. It works by blocking the proteins (CDK4/6) that allow cancer cells to divide and grow.
Key Benefits:
-
Slows progression of breast cancer significantly
-
Works synergistically with hormone therapies
-
Oral tablet — easy to administer at home
-
Improves progression-free survival in advanced breast cancer patients
Available Strengths:
-
Palbociclib 75mg Tablets
-
Palbociclib 100mg Tablets
-
Palbociclib 125mg Tablets
Mechanism of Action:
Palbociclib selectively inhibits cyclin-dependent kinases 4 and 6, thereby halting cancer cell cycle progression at the G1 phase.
Why Choose Palmer Wellness?
-
✅ 100% authentic and licensed oncology drugs
-
✅ Affordable pricing with global delivery
-
✅ Fast, secure packaging with tracking
Indications:
-
Advanced HR+ / HER2- breast cancer in postmenopausal women and men
-
Used with aromatase inhibitors (e.g., Letrozole) or Fulvestrant
Administration Advice:
-
Usually taken once daily for 21 days followed by 7 days off (28-day cycle)
-
Dose adjustments may be required based on patient tolerance
Storage Instructions:
Store at room temperature (15–30°C), away from moisture and direct sunlight.

Reviews
There are no reviews yet.